These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 13920554)
1. [Apomorphine synergism (inducedgnawing in mice) as a test for the differentiation of psychotropic substances]. THER L; SCHRAMM H Arch Int Pharmacodyn Ther; 1962 Jul; 138():302-10. PubMed ID: 13920554 [No Abstract] [Full Text] [Related]
2. Pharmacokinetic aspects of some behavioral effects of psychotropic drugs. Melzacka M Pol J Pharmacol Pharm; 1984; 36(2-3):117-36. PubMed ID: 6147827 [TBL] [Abstract][Full Text] [Related]
3. A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology. Donovan JL; DeVane CL Psychopharmacol Bull; 2001; 35(3):30-48. PubMed ID: 12397877 [TBL] [Abstract][Full Text] [Related]
4. [Effect of 3 new GABA-ergics on reserpine catalepsy and apomorphine sedation in rats]. Vamvakidès A Agressologie; 1987 May; 28(5):535-9. PubMed ID: 3661856 [No Abstract] [Full Text] [Related]
5. Influence of nootropic drugs on apomorphine-induced stereotyped behaviour in rats. Schmidt J Biomed Biochim Acta; 1990; 49(1):133-6. PubMed ID: 2360904 [TBL] [Abstract][Full Text] [Related]
6. Neurochemical correlates of differences in responses to psychotropic drugs. I. Apomorphine and morphine effects on locomotor activity of C57/BL and Balb/C mice. Marona-Lewicka D; Vetulani J Pol J Pharmacol Pharm; 1989; 41(5):431-8. PubMed ID: 2561888 [TBL] [Abstract][Full Text] [Related]
7. [Neuropsychotropic activity and toxicity of oxidation products of apomorphine]. Rehse K; Piesker G; Horowski R Arch Pharm (Weinheim); 1978 Apr; 311(4):360-3. PubMed ID: 655808 [No Abstract] [Full Text] [Related]
8. [Action of psychotropic substances on metabolism. 3]. OPITZ K Arzneimittelforschung; 1962 Jun; 12():618-26. PubMed ID: 14482119 [No Abstract] [Full Text] [Related]
9. [The effect of various new GABAergics on motor and oral stereotypes with apomorphine in the rat]. Vamvakidès A; Kassianidès A; Papadopoulou-Daifoti Z J Pharmacol; 1985; 16(4):403-11. PubMed ID: 4094437 [TBL] [Abstract][Full Text] [Related]
10. Psychopharmacology and psychosomatic disorders. Ban TA Psychosomatics; 1978 Dec; 19(12):757-60. PubMed ID: 734030 [No Abstract] [Full Text] [Related]
11. Synthesis and pharmacological properties of 2,4-disubstituted 5-amino-6-pyrimidinecarboxylic acid derivatives. Part III. Jasztold-Howorko R; Machoń Z; Wilimowski M; Wojewódzki W; Barczyńska J; Kedzierska L; Orzechowska-Juzwenko K; Duś E; Dziewiszek W; Rutkowska M Pol J Pharmacol; 1995; 47(5):435-40. PubMed ID: 8868136 [TBL] [Abstract][Full Text] [Related]
16. [Psychotropic substances]. LINKE H Munch Med Wochenschr; 1960 May; 102():995-1000 contd. PubMed ID: 14417281 [No Abstract] [Full Text] [Related]
17. [Psychotropic substances]. LINKE H Munch Med Wochenschr; 1960 May; 102():1069-74 concl. PubMed ID: 14417280 [No Abstract] [Full Text] [Related]
18. [PSYCHOLEPTIC ACTION OF METOCLOPRAMIDE]. BOISSIER JR; SIMON P; LWOFF JM; FICHELLE-PAGNY J C R Seances Soc Biol Fil; 1964; 158():1859-62. PubMed ID: 14262525 [No Abstract] [Full Text] [Related]
19. [2 new GABA-ergics (GABA-linoleamide and GABA-steatamide). On 2 experimental models of depression]. Vamvakidès A Agressologie; 1985 Jun; 26(7):597-9. PubMed ID: 4041141 [No Abstract] [Full Text] [Related]
20. [Practical remarks concerning the use of modern psychotropic substances]. ISRAEL L Strasb Med; 1960 Jan; 11():54-7. PubMed ID: 14405960 [No Abstract] [Full Text] [Related] [Next] [New Search]